PARTI Company Overview We are a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines. Our approved product CARDAMYST TM (etripamil) nasal spray is available in the United States and is the first and only FDA approved self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. We continue to seek, either directly or through collaboration with our partners, marketing approval from regulatory agencies respo...
Q2 FY2026 — expected 2026-08-09
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-20 | 2025-12-31 | 0001104659-26-032415 | EDGAR | 83K words |
| 2025-03-13 | 2024-12-31 | 0001558370-25-002849 | EDGAR | — |
| 2024-03-21 | 2023-12-31 | 0001558370-24-003666 | EDGAR | — |
| 2023-03-29 | 2022-12-31 | 0001558370-23-004871 | EDGAR | — |
| 2022-03-24 | 2021-12-31 | 0001558370-22-004205 | EDGAR | — |
| 2021-03-29 | 2020-12-31 | 0001558370-21-003631 | EDGAR | — |
| 2020-03-06 | 2019-12-31 | 0001558370-20-002106 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-12 | 2025-09-30 | 0001104659-25-109689 | EDGAR | 28K words |
| 2025-08-12 | 2025-06-30 | 0001558370-25-011141 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0001558370-25-007648 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001558370-24-015147 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001558370-24-011603 | EDGAR | — |
| 2024-05-13 | 2024-03-31 | 0001558370-24-007860 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0001558370-23-018665 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0001558370-23-014399 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0001558370-23-009254 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001558370-22-017283 | EDGAR | — |
| 2022-08-10 | 2022-06-30 | 0001558370-22-013074 | EDGAR | — |
| 2022-05-12 | 2022-03-31 | 0001558370-22-008418 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-20 | 0001104659-26-032427 | EDGAR | 4K words |
| 2026-01-26 | 0001104659-26-006483 | EDGAR | — |
| 2026-01-13 | 0001104659-26-003038 | EDGAR | — |
| 2026-01-06 | 0001104659-26-001099 | EDGAR | — |
| 2025-12-15 | 0001104659-25-120904 | EDGAR | — |
| 2025-11-12 | 0001104659-25-109744 | EDGAR | — |
| 2025-08-12 | 0001104659-25-076468 | EDGAR | — |
| 2025-07-14 | 0001104659-25-067579 | EDGAR | — |
| 2025-07-11 | 0001104659-25-067108 | EDGAR | — |
| 2025-06-16 | 0001104659-25-059671 | EDGAR | — |
124 total filings indexed. 95 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001408443 |
| Ticker | MIST |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | A8 |
| Website | https://www.milestonepharma.com |
| Listed | 2019-05-09 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/MIST (~200 tokens, structured JSON with cryptographic provenance)